Journal Home > Volume 15 , Issue 7
Nano Research 2022, 15(7): 6361-6371 https://doi.org/10.1007/s12274-022-4368-5
Research Article | Issue | Published: 07 May 2022

Hyaluronic acid-based dual-responsive nanomicelles mediated mutually synergistic photothermal and molecular targeting therapies

Show Author's Information Liangliang Cai1,§,  Ronghua Ni1,§,  Xiaofei Ma1,§,  Rongrong Huang1,  Zhiyuan Tang1,  Jinqiu Xu1,  Yong Han2( ),  Yuehua Guo3( ),  Zhifeng Gu4( )
Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong 226001, China
Department of Radiation Oncology, Affiliated Hospital of Nantong University, Nantong 226001, China
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China
Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong 226001, China

§ Liangliang Cai, Ronghua Ni, and Xiaofei Ma contributed equally to this work.

Keywords:
hyaluronic acid, photothermal therapy, nanomicelles, dual responsive, molecular targeting therapy
Topics:
Drug therapy
Cite this article:
Cai L, Ni R, Ma X, et al. Hyaluronic acid-based dual-responsive nanomicelles mediated mutually synergistic photothermal and molecular targeting therapies. Nano Research, 2022, 15(7): 6361-6371. https://doi.org/10.1007/s12274-022-4368-5
Download citation
EndNote(RIS)
BibTeX

790

Views

89

Downloads

Citations

7

Crossref

6

WoS

6

Scopus

0

CSCD

Abstract Full text Electronic supplementary material About this article

Precise clinical treatment of triple-negative breast cancer (TNBC) is an obstacle in clinic. Nanotechnology-assisted photothermal therapy (PTT) is a superior treatment modality for TNBC in terms of precision. However, thermoresistance arising from PTT and insufficient drug release from nanocarriers decrease the efficacy of PTT. AT13387 is a novel HSP90 inhibitor that can weaken thermoresistance and undergoing clinic II phase study, showing satisfactory antitumour activity through molecularly targeted therapy (MTT). Whereas, it has poor solubility. Hence hyaluronic acid and stearic acid were connected by hydrazone bonds and disulfide bonds, forming an amphipathic copolymer that could self-assembled into nanomicelles, followed by encapsulating Cypate and AT13387. These nanomicelles exhibited great features, including achieving mutually synergistic PTT/MTT for overcoming thermoresistance and promoting translocation of drugs, increasing the solubility of Cypate and AT13387, showing a pH/redox dual response that contributes to drug release, and having the ability of active targeting. Thus, the nanomicelles developed in this study may be a promising strategy for the precise treatment of TNBC.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

Hyaluronic acid-based dual-responsive nanomicelles mediated mutually synergistic photothermal and molecular targeting therapies

Show Author's information Liangliang Cai1,§, Ronghua Ni1,§, Xiaofei Ma1,§, Rongrong Huang1, Zhiyuan Tang1, Jinqiu Xu1, Yong Han2( ), Yuehua Guo3( ), Zhifeng Gu4( )
Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong 226001, China
Department of Radiation Oncology, Affiliated Hospital of Nantong University, Nantong 226001, China
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China
Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong 226001, China

§ Liangliang Cai, Ronghua Ni, and Xiaofei Ma contributed equally to this work.

Abstract

Precise clinical treatment of triple-negative breast cancer (TNBC) is an obstacle in clinic. Nanotechnology-assisted photothermal therapy (PTT) is a superior treatment modality for TNBC in terms of precision. However, thermoresistance arising from PTT and insufficient drug release from nanocarriers decrease the efficacy of PTT. AT13387 is a novel HSP90 inhibitor that can weaken thermoresistance and undergoing clinic II phase study, showing satisfactory antitumour activity through molecularly targeted therapy (MTT). Whereas, it has poor solubility. Hence hyaluronic acid and stearic acid were connected by hydrazone bonds and disulfide bonds, forming an amphipathic copolymer that could self-assembled into nanomicelles, followed by encapsulating Cypate and AT13387. These nanomicelles exhibited great features, including achieving mutually synergistic PTT/MTT for overcoming thermoresistance and promoting translocation of drugs, increasing the solubility of Cypate and AT13387, showing a pH/redox dual response that contributes to drug release, and having the ability of active targeting. Thus, the nanomicelles developed in this study may be a promising strategy for the precise treatment of TNBC.

Keywords: hyaluronic acid, photothermal therapy, nanomicelles, dual responsive, molecular targeting therapy

References(43)

1

Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249.
DOI Google Scholar
2

Sun, W.; Du, Y.; Liang, X. L.; Yu, C. Y.; Fang, J. J.; Lu, W.; Guo, X. Y.; Tian, J.; Jin, Y. H.; Zheng, J. J. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer. Biomaterials 2019, 217, 119264.
DOI Google Scholar
3

Hwang, S. Y.; Park, S.; Kwon, Y. Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol. Ther. 2019, 199, 30–57.
DOI Google Scholar
4

Bianchini, G.; Balko, J. M.; Mayer, I. A.; Sanders, M. E.; Gianni, L. Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 2016, 13, 674–690.
DOI Google Scholar
5

Jusu, S. M.; Obayemi, J. D.; Salifu, A. A.; Nwazojie, C. C.; Uzonwanne, V.; Odusanya, O. S.; Soboyejo, W. O. Drug-encapsulated blend of PLGA-PEG microspheres: In vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer. Sci. Rep. 2020, 10, 14188.
DOI Google Scholar
6

Tian, Y.; Wang, X. F.; Zhao, S.; Liao, X.; Younis, M. R.; Wang, S. J.; Zhang, C. N.; Lu, G. M. JQ1-loaded polydopamine nanoplatform inhibits c-MYC/programmed cell death ligand 1 to enhance photothermal therapy for triple-negative breast cancer. ACS Appl. Mater. Interfaces 2019, 11, 46626–46636.
DOI Google Scholar
7

Qiao, J. N.; Tian, F. C.; Deng, Y. D.; Shang, Y. K.; Chen, S. J.; Chang, E. H.; Yao, J. Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer. Theranostics 2020, 10, 5305–5321.
DOI Google Scholar
8

Yang, J. C.; Chen, Y.; Li, Y. H.; Yin, X. B. Magnetic resonance imaging-guided multi-drug chemotherapy and photothermal synergistic therapy with pH and NIR-stimulation release. ACS Appl. Mater. Interfaces 2017, 9, 22278–22288.
DOI Google Scholar
9

Huang, L. P.; Li, Y. N.; Du, Y. N.; Zhang, Y. Y.; Wang, X. X.; Ding, Y.; Yang, X. L.; Meng, F. L.; Tu, J. S.; Luo, L. et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat. Commun. 2019, 10, 4871.
DOI Google Scholar
10

Li, Y. L.; Deng, Y. B.; Tian, X.; Ke, H. T.; Guo, M.; Zhu, A. J.; Yang, T.; Guo, Z. Q.; Ge, Z. S.; Yang, X. L. et al. Multipronged design of light-triggered nanoparticles to overcome cisplatin resistance for efficient ablation of resistant tumor. ACS Nano 2015, 9, 9626–9637.
DOI Google Scholar
11

Tian, Y.; Guo, R. R.; Wang, Y. J.; Yang, W. L. Coordination-induced assembly of intelligent polysaccharide-based phototherapeutic nanoparticles for cancer treatment. Adv. Healthc. Mater. 2016, 5, 3099–3104.
DOI Google Scholar
12

Yang, H.; Mao, H. J.; Wan, Z. H.; Zhu, A. J.; Guo, M.; Li, Y. L.; Li, X. M.; Wan, J. L.; Yang, X. L.; Shuai, X. T. et al. Micelles assembled with carbocyanine dyes for theranostic near-infrared fluorescent cancer imaging and photothermal therapy. Biomaterials 2013, 34, 9124–9133.
DOI Google Scholar
13

Yang, Y.; Zhu, W. J.; Dong, Z. L.; Chao, Y.; Xu, L.; Chen, M. W.; Liu, Z. 1D coordination polymer nanofibers for low-temperature photothermal therapy. Adv. Mater. 2017, 29, 1703588.
DOI Google Scholar
14

Zhu, X. J.; Feng, W.; Chang, J.; Tan, Y. W.; Li, J. C.; Chen, M.; Sun, Y.; Li, F. Y. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature. Nat. Commun. 2016, 7, 10437.
DOI Google Scholar
15

Chang, M. Y.; Hou, Z. Y.; Wang, M.; Yang, C. Z.; Wang, R. F.; Li, F.; Liu, D. L.; Peng, T. L.; Li, C. X.; Lin, J. Single-atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy. Angew. Chem., Int. Ed. 2021, 60, 12971–12979.
DOI Google Scholar
16

An, X. N.; Zhu, A. J.; Luo, H. H.; Ke, H. T.; Chen, H. B.; Zhao, Y. L. Rational design of multi-stimuli-responsive nanoparticles for precise cancer therapy. ACS Nano 2016, 10, 5947–5958.
DOI Google Scholar
17

Chen, L.; Zhou, L. L.; Wang, C. H.; Han, Y.; Lu, Y. L.; Liu, J.; Hu, X. C.; Yao, T. M.; Lin, Y.; Liang, S. J. et al. Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers. Adv. Mater. 2019, 31, 1904997.
DOI Google Scholar
18

Wang, Z. H.; Li, S. W.; Zhang, M.; Ma, Y.; Liu, Y. X.; Gao, W. D.; Zhang, J. Q.; Gu, Y. Q. Laser-triggered small interfering RNA releasing gold nanoshells against heat shock protein for sensitized photothermal therapy. Adv. Sci. 2017, 4, 1600327.
DOI Google Scholar
19

Wen, Z. F.; Liu, F. Y.; Liu, G. X.; Sun, Q. Y.; Zhang, Y. H.; Muhammad, M.; Xu, Y. Q.; Li, H. J.; Sun, S. G. Assembly of multifunction dyes and heat shock protein 90 inhibitor coupled to bovine serum albumin in nanoparticles for multimodal photodynamic/photothermal/chemo-therapy. J. Colloid Interface Sci. 2021, 590, 290–300.
DOI Google Scholar
20

Li, J. H.; Zhu, D. M.; Ma, W. J.; Yang, Y.; Wang, G. G.; Wu, X. L.; Wang, K. L.; Chen, Y. R.; Wang, F. B.; Liu, W. et al. Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma. Nanoscale 2020, 12, 17064–17073.
DOI Google Scholar
21

Yang, R.; Tang, Q. S.; Miao, F. Q.; An, Y. L.; Li, M. F.; Han, Y.; Wang, X. H.; Wang, J.; Liu, P. D.; Chen, R. Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice. Int. J. Nanomedicine 2015, 10, 7345–7358.
DOI Google Scholar
22

Woodhead, A. J.; Angove, H.; Carr, M. G.; Chessari, G.; Congreve, M.; Coyle, J. E.; Cosme, J.; Graham, B.; Day, P. J.; Downham, R. et al. Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design. J. Med. Chem. 2010, 53, 5956–5969.
DOI Google Scholar
23

Spiegelberg, D.; Abramenkovs, A.; Mortensen, A. C. L.; Lundsten, S.; Nestor, M.; Stenerlöw, B. The HSP90 inhibitor onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: An in vitro and in vivo approach. Sci. Rep. 2020, 10, 5923.
DOI Google Scholar
24

Hu, J. J.; Cheng, Y. J.; Zhang, X. Z. Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale 2018, 10, 22657–22672.
DOI Google Scholar
25

Lin, W. J.; Lee, W. C.; Shieh, M. J. Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery. Carbohydr. Polym. 2017, 155, 101–108.
DOI Google Scholar
26

Lee, W. H.; Rho, J. G.; Han, H. S.; Kweon, S.; Nguyen, V. Q.; Park, J. H.; Kim, W. Self-assembled hyaluronic acid nanoparticle suppresses fat accumulation via CD44 in diet-induced obese mice. Carbohydr. Polym. 2020, 237, 116161.
DOI Google Scholar
27
Cui T. T. Yan Z. Q. Qin H. S. Sun Y. H. Ren J. S. Qu X. G. A sequential target-responsive nanocarrier with enhanced tumor penetration and neighboring effect in vivo Small 2019 15 1903323 10.1002/smll.201903323

Cui, T. T. ; Yan, Z. Q. ; Qin, H. S. ; Sun, Y. H. ; Ren, J. S. ; Qu, X. G. A sequential target-responsive nanocarrier with enhanced tumor penetration and neighboring effect in vivo. Small 2019, 15, 1903323.
DOI Google Scholar
28

Li, Q. L.; Liu, J.; Fan, H. L.; Shi, L.; Deng, Y.; Zhao, L.; Xiang, M. X.; Xu, Y. R.; Jiang, X. L.; Wang, G. B. et al. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment. Biomaterials 2021, 269, 120388.
DOI Google Scholar
29

Wang, S.; Yu, G. C.; Wang, Z. T.; Jacobson, O.; Lin, L. S.; Yang, W. J.; Deng, H. Z.; He, Z. M.; Liu, Y.; Chen, Z. Y. et al. Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release. Angew. Chem., Int. Ed. 2019, 58, 14758–14763.
DOI Google Scholar
30

Kim, H. U.; Choi, D. G.; Lee, H.; Shim, M. S.; Bong, K. W. Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release. Lab Chip 2018, 18, 754–764.
DOI Google Scholar
31

Jiang, X. L.; Fan, X. B.; Xu, W.; Zhao, C. G.; Wu, H. L.; Zhang, R.; Wu, G. Q. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug. J. Control. Release 2019, 316, 196–207.
DOI Google Scholar
32

Cheng, K. M.; Ding, Y. P.; Zhao, Y.; Ye, S. F.; Zhao, X.; Zhang, Y. L.; Ji, T. J.; Wu, H. H.; Wang, B.; Anderson, G. J. et al. Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano Lett. 2018, 18, 3250–3258.
DOI Google Scholar
33

Jin, R.; Sun, J.; Zhou, L. F.; Guo, X. L.; Cao, A. N. Dual-responsive click-crosslinked micelles designed for enhanced chemotherapy for solid tumors. Biomater. Sci. 2020, 8, 2507–2513.
DOI Google Scholar
34

Phan, H.; Taresco, V.; Penelle, J.; Couturaud, B. Polymerisation-induced self-assembly (PISA) as a straightforward formulation strategy for stimuli-responsive drug delivery systems and biomaterials: Recent advances. Biomater. Sci. 2021, 9, 38–50.
DOI Google Scholar
35

Lo, Y. L.; Tsai, M. F.; Soorni, Y.; Hsu, C.; Liao, Z. X.; Wang, L. F. Dual stimuli-responsive block copolymers with adjacent redox- and photo-cleavable linkages for smart drug delivery. Biomacromolecules 2020, 21, 3342–3352.
DOI Google Scholar
36

Jie, K. C.; Zhou, Y. J.; Sun, Q.; Li, B.; Zhao, R.; Jiang, D. E.; Guo, W.; Chen, H.; Yang, Z. Z.; Huang, F. H. et al. Mechanochemical synthesis of pillar[5]quinone derived multi-microporous organic polymers for radioactive organic iodide capture and storage. Nat. Commun. 2020, 11, 1086.
DOI Google Scholar
37

Chen, R. F.; Wang, Y.; Ma, Y.; Mal, A.; Gao, X. Y.; Gao, L.; Qiao, L. J.; Li, X. B.; Wu, L. Z.; Wang, C. Rational design of isostructural 2D porphyrin-based covalent organic frameworks for tunable photocatalytic hydrogen evolution. Nat. Commun. 2021, 12, 1354.
DOI Google Scholar
38

Zhao, D. C.; Yang, N. L.; Wei, Y.; Jin, Q.; Wang, Y. L.; He, H. Y.; Yang, Y.; Han, B.; Zhang, S. J.; Wang, D. Sequential drug release via chemical diffusion and physical barriers enabled by hollow multishelled structures. Nat. Commun. 2020, 11, 4450.
DOI Google Scholar
39

Yin, S. P.; Huai, J.; Chen, X.; Yang, Y.; Zhang, X. X.; Gan, Y.; Wang, G. J.; Gu, X. C.; Li, J. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater. 2015, 26, 274–285.
DOI Google Scholar
40

Chi, Y. Y.; Yin, X. L.; Sun, K. X.; Feng, S. S.; Liu, J. H.; Chen, D. Q.; Guo, C. Y.; Wu, Z. M. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. J. Control. Release 2017, 261, 113–125.
DOI Google Scholar
41

Pant, K.; Neuber, C.; Zarschler, K.; Wodtke, J.; Meister, S.; Haag, R.; Pietzsch, J.; Stephan, H. Active targeting of dendritic polyglycerols for diagnostic cancer imaging. Small 2020, 16, 1905013.
DOI Google Scholar
42

Isaacs, J. S. Hsp90 as a “chaperone” of the epigenome: Insights and opportunities for cancer therapy. Adv. Cancer Res. 2016, 129, 107–140.
DOI Google Scholar
43

Roberts, P. J.; Der, C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26, 3291–3310.
DOI Google Scholar
File
12274_2022_4368_MOESM1_ESM.pdf (1 MB)
Publication history
Copyright
Acknowledgements

Publication history

Received: 12 February 2022
Revised: 25 March 2022
Accepted: 28 March 2022
Published: 07 May 2022
Issue date: July 2022

Copyright

© Tsinghua University Press 2022

Acknowledgements

Acknowledgements

This work was financially supported by the National Natural Science Foundation of China (No. 81900528), the China Postdoctoral Science Foundation (Nos. 2019M661908 and 2018M642297), the Postdoctoral Science Foundation of Jiangsu Province (No. 2020Z435), and the Science and technology Program of Nantong City (No. JC2021150).

Return